Nuclear Medicine and Biology
Volume 34, Issue 3 , Pages 305-314 , April 2007

In vitro characterization of the thyroidal uptake of O-(2-[18F]fluoroethyl)-l-tyrosine

Received 29 November 2006 ,Revised 5 December 2006 ,Accepted 17 December 2006.

References 

  1. Grünwald F, Kalicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med. 1999;26:1547–1552
  2. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–1980
  3. Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T. Uptake of [18F]fluorodeoxyglucose in human monocyte–macrophages in vitro. Eur J Nucl Med Mol Imaging. 2003;30:267–273
  4. Maschauer S, Prante O, Hoffmann M, Deichen JT, Kuwert T. Characterization of 18F-FDG uptake in human endothelial cells in vitro. J Nucl Med. 2004;45:455–460
  5. Rau FC, Weber WA, Wester HJ, Herz M, Becker I, Kruger A, et al. O-(2-[18F]fluoroethyl)-l-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imaging. 2002;29:1039–1046
  6. Kaim AH, Weber B, Kurrer MO, Westera G, Schweitzer A, Gottschalk J, et al. F-18-FDG and F-18-FET uptake in experimental soft tissue infection. Eur J Nucl Med Mol Imaging. 2002;29:648–654
  7. Spaeth N, Wyss MT, Weber B, Scheidegger S, Lutz A, Verwey J, et al. Uptake of F-18-fluorocholine, F-18-fluoroethyl-l-tyrosine, and F-18-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumor recurrence. J Nucl Med. 2004;45:1931–1938
  8. Prante O, Deichen JT, Hocke C, Kuwert T. Characterization of uptake of 3-[131I]iodo-α-methyl-l-tyrosine in human monocyte–macrophages. Nucl Med Biol. 2004;31:365–372
  9. Jager PL, Vaalburg W, Pruim J, de Vries EGE, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42:432–445
  10. Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-l-tyrosine for tumor imaging. J Nucl Med. 1999;40:205–212
  11. Hamacher K, Coenen HH. Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-l-tyrosine. Appl Radiat Isot. 2002;57:853–856
  12. Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Muller HW, et al. O-(2-[18F]fluoroethyl)-l-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain. 2005;128:678–687
  13. Floeth FW, Pauleit D, Wittsack HJ, Langen KJ, Reifenberger G, Hamacher K, et al. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with F-18 fluoroethyl-l-tyrosine and magnetic resonance spectroscopy. J Neurosurg. 2005;102:318–327
  14. Pöpperl G, Goldbrunner R, Gildehaus FJ, Kreth FW, Tanner P, Holtmannspötter M, et al. O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging. 2005;32:1018–1025
  15. Pauleit D, Stoffels G, Schaden W, Hamacher K, Bauer D, Tellmann L, et al. PET with O-(2-[18F]fluoroethyl)-l-tyrosine in peripheral tumors: first clinical results. J Nucl Med. 2005;46:411–416
  16. Langen K-J, Hamacher K, Weckesser M, Floeth F, Stoffels G, Bauer D, et al. O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287–294
  17. Heiss P, Mayer A, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-l-tyrosine in vitro and in vivo. J Nucl Med. 1999;40:1367–1373
  18. Palacin M, Estevez R, Bertran J, Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev. 1998;78:969–1054
  19. Langen KJ, Jarosch M, Muhlensiepen H, Hamacher K, Broer S, Jansen P, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol. 2003;30:501–508
  20. Stöber B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-l-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging. 2006;33:932–939
  21. Mruck S, Pfahlberg A, Papadopoulos T, Stremmel C, Kuwert T. Uptake of 201Tl into primary cell cultures from human thyroid tissue is multiplied by TSH. J Nucl Med. 2002;43:145–152
  22. Deichen JT, Schmidt C, Prante O, Maschauer S, Papadopoulos T, Kuwert T. Influence of TSH on uptake of [18F]fluorodeoxyglucose in human thyroid cells in vitro. Eur J Nucl Med Mol Imaging. 2004;31:507–512
  23. Bläser D, Maschauer S, Kuwert T, Prante O. In vitro studies on the signal transduction of thyroidal uptake of 18F-FDG and 131I-iodide. J Nucl Med. 2006;47:1382–1388
  24. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem. 1976;72:248–254
  25. Ambesi-Impiombato FS, Picone R, Tramontano D. Influence of hormones and serum on growth and differentiation of the thyroid cell strain FRTL. In:  Sato GH,  Pardee AB,  Sirbaku DA editor. Growth of cells in hormonally defined media. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1982;p. 483–492
  26. Brandi ML, Rotella CM, Mavilia C, Franceschelli F, Tanini A, Toccafondi R. Insulin stimulates cell growth of a new strain of differentiated rat thyroid cells. Mol Cell Endocrinol. 1987;54:91–103
  27. Kimura T, Dumont JE, Fusco A, Golstein J. Insulin and TSH promote growth in size of PC Cl3 rat thyroid cells, possibly via a pathway different from DNA synthesis: comparison with FRTL-5 cells. Eur J Endocrinol. 1999;140:94–103
  28. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE, Roger PP. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev. 2001;22:631–656
  29. Hosaka Y, Tawata M, Kurihara A, Ohtaka M, Endo T, Onaya T. The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology. 1992;131:159–165
  30. Samih N, Hovsepian S, Aouani A, Lombardo D, Fayet G. Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation. Endocrinology. 2000;141:4146–4155
  31. Russo D, Damante G, Foti D, Costante G, Filetti S. Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL5 rat thyroid cells. J Endocrinol Invest. 1994;17:323–327
  32. Spitzweg C, Joba W, Morris JC, Heufelder AE. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid. 1999;9:821–830
  33. Pang XP, Park M, Hershman JM. Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells. Endocrinology. 1992;131:45–50
  34. Santisteban P, Kohn LD, Di Lauro R. Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells. J Biol Chem. 1987;262:4048–4052
  35. Lee NT, Nayfeh SN, Chae CB. Induction of nuclear protein factors specific for hormone-responsive region during activation of thyroglobulin gene by thyrotropin in rat thyroid FRTL-5 cells. J Biol Chem. 1989;264:7523–7530
  36. Grimm D, Hofstadter F, Bauer J, Spruss T, Steinbach P, Bernhardt G, et al. Establishment and characterization of a human papillary thyroid carcinoma cell line with oxyphilic differentiation (ONCO-DG 1). Virchows Arch B Cell Pathol. 1992;62:97–104
  37. Schönberger J, Bauer J, Spruss T, Weber G, Chahoud I, Eilles C, et al. Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med. 2000;78:102–110
  38. Pauleit D, Floeth F, Herzog H, Hamacher K, Tellmann L, Muller H-W, et al. Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine. Eur J Nucl Med Mol Imaging. 2003;30:519–524
  39. Mansi L, Moncayo R, Cuccurullo V, Dottorini ME, Rambaldi PF. Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer. Q J Nucl Med Mol Imaging. 2004;48:82–95
  40. Tietze F, Kohn LD, Kohn AD, Bernardini I, Andersson HC, Adamson MD, et al. Carrier-mediated transport of monoiodotyrosine out of thyroid cell lysosomes. J Biol Chem. 1989;264:4762–4765
  41. Andersson HC, Kohn LD, Bernardini I, Blom HJ, Tietze F, Gahl WA. Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system h. J Biol Chem. 1990;265:10950–10954
  42. Bernar J, Tietze F, Kohn LD, Bernardini I, Harper GS, Grollman EF, et al. Characteristics of a lysosomal membrane transport system for tyrosine and other neutral amino acids in rat thyroid cells. J Biol Chem. 1986;261:17107–17112
  43. Deves R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev. 1998;78:487–545
  44. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem. 1998;273:23629–23632
  45. Pineda M, Fernandez E, Torrents D, Estevez R, Lopez C, Camps M, et al. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem. 1999;274:19738–19744
  46. Segawa H, Fukasawa Y, Miyamoto K-I, Takeda E, Endou H, Kanai Y. Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem. 1999;274:19745–19751
  47. Babu E, Kanai Y, Chairoungdua A, Kim do K, Iribe Y, Tangtrongsup S, et al. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003;278:43838–43845
  48. Bodoy S, Martin L, Zorzano A, Palacin M, Estevez R, Bertran J. Identification of LAT4, a novel amino acid transporter with system L activity. J Biol Chem. 2005;280:12002–12011
  49. Shotwell MA, Jayme DW, Kilberg MS, Oxender DL. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem. 1981;256:5422–5427
  50. Lahoutte T, Caveliers V, Dierickx L, Vekeman M, Everaert H, Mertens J, et al. In vitro characterization of the influx of 3-[125I]iodo-l-alpha-methyltyrosine and 2-[125I]iodo-l-tyrosine into U266 human myeloma cells: evidence for system T transport. Nucl Med Biol. 2001;28:129–134
  51. Langen KJ, Pauleit D, Coenen HH. 3-[123I]Iodo-alpha-methyl-l-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2002;29:625–631
  52. Langen KJ, Muhlensiepen H, Holschbach M, Hautzel H, Jansen P, Coenen HH. Transport mechanisms of 3-[123I]iodo-alpha-methyl-l-tyrosine in a human glioma cell line: comparison with [3H]methyl]-l-methionine. J Nucl Med. 2000;41:1250–1255
  53. Sloan JL, Mager S. Cloning and functional expression of a human Na+ and Cl−-dependent neutral and cationic amino acid transporter B0+. J Biol Chem. 1999;274:23740–23745
  54. Verri T, Dimitri C, Treglia S, Storelli F, De Micheli S, Ulianich L, et al. Multiple pathways for cationic amino acid transport in rat thyroid epithelial cell line PC Cl3. Am J Physiol Cell Physiol. 2005;288:C290–C303
  55. Lahoutte T, Caveliers V, Camargo SM, Franca R, Ramadan T, Veljkovic E, et al. SPECT and PET amino acid tracer influx via system L (h4F2hc–hLAT1) and its transstimulation. J Nucl Med. 2004;45:1591–1596
  56. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP, Hennemann G, et al. Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology. 2001;142:4339–4348

PII: S0969-8051(07)00006-6

doi: 10.1016/j.nucmedbio.2006.12.007

Nuclear Medicine and Biology
Volume 34, Issue 3 , Pages 305-314 , April 2007

Article Tools

* Image Usage & Resolution